Reach Resources Limited (ASX:RR1)

Checkpoint Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	4.43	6.01	1.23	1.13	2.03	0.15
Trading Asset Securities	-	-	-	-	0.01	0.32
Cash & Short-Term Investments	4.43	6.01	1.23	1.13	2.04	0.47
Cash Growth	89.97%	389.12%	8.41%	-44.37%	335.22%	279.34%
Other Receivables	0.11	0.05	0.13	0.02	0.02	-
Receivables	0.11	0.05	0.13	0.02	0.02	-
Prepaid Expenses	-	0.01	0.01	0	-	-
Total Current Assets	4.54	6.08	1.37	1.15	2.06	0.47
Property, Plant & Equipment	9.94	8.95	5.18	3.06	1.89	1.68
Long-Term Investments	-	-	-	1.87	-	-
Total Assets	14.48	15.02	6.55	6.08	3.95	2.15
Accounts Payable	0.14	0.31	0.52	0.11	0.04	0.36
Accrued Expenses	0.02	0.03	0.01	-	-	-
Short-Term Debt	-	-	-	-	-	0.11
Current Portion of Long-Term Debt	-	-	-	0.45	0.45	-
Total Current Liabilities	0.16	0.34	0.52	0.56	0.49	0.47
Long-Term Debt	-	-	-	-	-	0.9
Total Liabilities	0.16	0.34	0.52	0.56	0.49	1.37
Common Stock	28.89	28.89	22.47	19.34	17.14	14.12
Retained Earnings	-15	-14.54	-16.79	-14.13	-13.67	-13.33
Comprehensive Income & Other	0.43	0.33	0.35	0.31	-	-
Shareholders' Equity	14.32	14.69	6.03	5.53	3.46	0.78
Total Liabilities & Equity	14.48	15.02	6.55	6.08	3.95	2.15
Total Debt	-	-	-	0.45	0.45	1.01
Net Cash (Debt)	4.43	6.01	1.23	0.68	1.59	-0.54
Net Cash Growth	89.97%	389.12%	79.70%	-56.93%	-	-
Net Cash Per Share	0.00	0.01	0.00	0.00	0.01	-0.01
Filing Date Shares Outstanding	874.43	874.43	631.01	382.01	310.8	107.2
Total Common Shares Outstanding	874.43	874.43	551.01	382.01	310.8	107.2
Working Capital	4.39	5.74	0.85	0.6	1.57	-0
Book Value Per Share	0.02	0.02	0.01	0.01	0.01	0.01
Tangible Book Value	14.32	14.69	6.03	5.53	3.46	0.78
Tangible Book Value Per Share	0.02	0.02	0.01	0.01	0.01	0.01
Machinery	-	0.08	0.07	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.